RT15 15mg*10vials

Retatrutide RT15 15mg*10vials

Retatrutide is a triple-receptor agonist peptide that activates GLP-1, GIP, and glucagon receptors, representing a next-generation metabolic research compound.

The 15mg single-vial specification offers a balanced concentration, well-suited for medium-dose gradient experiments and long-term metabolic research projects. The higher content per vial compared to 10mg reduces the number of vials needed for extended studies, improving experimental efficiency.

Triple-pathway activation works across multiple metabolic systems. GLP-1 and GIP receptor engagement supports insulin sensitivity and appetite-related signaling research. Glucagon receptor activation contributes to energy expenditure and lipid metabolism studies.

This product is supplied as sterile lyophilized powder in glass vials, designed for reconstitution with appropriate solvents. Each batch is quality-tested with a certificate of analysis provided.

10 vials per pack, suitable for professional laboratory research applications.